MB Financial Bank - Trust Department’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

MB Financial Bank - Trust Department’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-10,000	Closed	-$6K	–	656
2015 Q3	$6K	Hold	10,000	–	–	﹤0.01%	433
2015 Q2	$5K	Hold	10,000	–	–	﹤0.01%	444
2015 Q1	$8K	Hold	10,000	–	–	﹤0.01%	369
2014 Q4	$8K	Sell	10,000 -30,000	-75%	-$27.4K	﹤0.01%	397
2014 Q3	$37K	Buy	40,000 +20,000	+100%	+$19.4K	﹤0.01%	404
2014 Q2	$17K	Buy	+20,000	New	+$24K	﹤0.01%	401

Other funds holding PVCT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HFBOT

Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

MB Financial Bank - Trust Department's PVCT Position: Q4 2015 in Review

MB Financial Bank - Trust Department sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2015, closing a stake of 10,000 shares — an estimated $6K sold.

MB Financial Bank - Trust Department first reported a position in PVCT in Q2 2014 and held it in 6 quarters. The position peaked at $37K in Q3 2014. 43 funds tracked by Wall St. Rank hold PVCT as of Q4 2015.

MB Financial Bank - Trust Department reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2015 after selling out during the quarter.
MB Financial Bank - Trust Department sold 10,000 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2015, an estimated $6K.
MB Financial Bank - Trust Department first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q2 2014 and held it in 6 quarters.
MB Financial Bank - Trust Department's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $37K in Q3 2014.
43 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2015.

Based on MB Financial Bank - Trust Department's 13F filing for Q4 2015, filed 7 Jan 2016.